The CRISPR/Cas9 technology was used to insert the internal ribosome entry site (IRES)-Cre cassette, the woodchuck hepatitis virus posttranscriptional regulatory element (wpre), and a polyA sequence between the translational stop codon and the 3' UTR of the endogenous Myh6 gene.